Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Seretide Settlement To Lift Glenmark’s Europe Business

Tue, 02/18/2020 - 2:21pm

Glenmark can sell its partnered generic rival to GSK’s Seretide Accuhaler dry powder inhaler in certain European markets following a...

      Related Stories 

Tech Transfer Roundup: Be Cool Therapeutics Sees Potential In Mimicking Hibernation

Tue, 02/18/2020 - 12:51pm

Biotech licenses drug composition patents from University of Alaska Fairbanks for study in several disease states. Gilead seeks long-acting HIV...

      Related Stories 

Interview: Novartis's Big Hopes For Beovu

Tue, 02/18/2020 - 8:15am

After a strong start in the US, Novartis is now ready to take on Bayer's wet age-related macular degeneration blockbuster...

      Related Stories 

Flu Vaccine Leader Sanofi Joins Fight Against COVID-19

Tue, 02/18/2020 - 8:09am

As the coronavirus continues to spread, one of the big four global vaccines companies has committed itself to the fight.

      Related Stories 

Sobi Reaps Benefits From Acquisitions, Commercial Focus

Tue, 02/18/2020 - 7:10am

Sweden’s mid-sized pharmaceutical company, Swedish Orphan Biovitrum, has expanded into hematology and strengthened its immunology business, growing its top and...

      Related Stories 

A Runaway Hit In US, Pfizer Gains EU Nod for Vyndaqel In Cardiomyopathy

Tue, 02/18/2020 - 5:18am

Vydaqel saw its uptake take off in the US last year. UK’s NICE to pass judgement on cost effectiveness by...

      Related Stories 

Helixmith Mods Engensis Trial Plans As Probe Unravels PK Anomalies

Mon, 02/17/2020 - 4:46pm

After probing pharmacokinetic data flaws in the first US Phase III study for its gene therapy Engensis, Korea's Helixmith concludes...

      Related Stories 

Ex-Janssen India Chief To Lead PE-Controlled Bharat Serums

Mon, 02/17/2020 - 3:05pm

Former managing director of Janssen India to helm Bharat Serums and Vaccines following the firm’s acquisition by private equity firm...

      Related Stories 

With BMS Set To Join, What Next For CAR-T Market?

Mon, 02/17/2020 - 7:18am

CAR-T therapies are groundbreaking in clinical terms, but have hit barriers in uptake. Can BMS’s challenger go one better than...

      Related Stories 

Stockwatch: Coronavirus Takes A Bite Out Of AstraZeneca’s Guidance, GSK and AbbVie Get Spinning

Mon, 02/17/2020 - 5:11am

The Coronavirus outbreak makes its first dent into pharma's 2020 prospects as AstraZeneca admits possible impact, while could AbbVie's aesthetic...

      Related Stories 

Interview: Spain's Sanifit Set For Significant 2020

Mon, 02/17/2020 - 3:15am

The Mallorca-based biotech is building a strong data package for SNF472 which the company believes will be an effective treatment...

      Related Stories 

BrightGene Bets On Remdesivir Amid Patent Questions

Sun, 02/16/2020 - 8:38pm

Despite many uncertainties, Suzhou-based BrightGene sees a bet on generic remdesivir worthy of a $700,000 investment.

      Related Stories 

Global Catastrophe Or Passing Nuisance? Pharma’s Coronavirus Views

Sun, 02/16/2020 - 3:51pm

While the global health threat from the now officially named SARS-CoV-2 coronavirus has grown since the start of the quarterly...

      Related Stories 

Sandoz Optimistic On Biosimilars As It Reprioritizes US Portfolio

Fri, 02/14/2020 - 12:15pm

Sandoz US president Carol Lynch talked to Scrip about its changing US portfolio, which will emphasize biosimilars, as the Novartis...

      Related Stories 

Asia Deal Watch: Strides Obtains 18 US ANDAs From Pharmaceutics

Fri, 02/14/2020 - 12:03pm

Deal news from Strides Pharma, Pharmaceutics Intl., Cipla, Wanbury, AstraZeneca, Syntekabio, Arctoris, Mundipharma, Samsung Bioepis…

      Related Stories 

Pipeline Watch: Phase III Readouts In Fabry Disease, Uterine Fibroids

Fri, 02/14/2020 - 7:10am

Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...

      Related Stories 

Ipsen Upbeat Despite Palovarotene Pain

Fri, 02/14/2020 - 5:50am

The French drugmaker's current product portfolio is performing well but a €669m charge relating to the failure of palovarotene for...

      Related Stories 

As Belviq Goes Off India Market, Patent Case May Fizzle

Fri, 02/14/2020 - 5:24am

Eisai and partner Sun to take lorcaserin off the Indian market. It remains to be seen whether the Japanese firm...

      Related Stories 

AstraZeneca Returns To Growth, But Coronavirus Likely To Hit China Revenues

Fri, 02/14/2020 - 12:36am

With a long turnaround process now complete, AstraZeneca could hit double digit growth in 2020, thanks to existing products and new...

      Related Stories 

Pages